RALEIGH, N.C., Aug. 16, 2011 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) a pharmaceutical drug development company, highlights a number of achievements disclosed in the Company’s quarterly report (Form 10-Q) filed with the Securities & Exchange Commission (SEC) on August 12, 2011 and provides an overview.
